• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于改良噬斑法的肠道病毒 71 型抗病毒药物筛选系统:一种有潜力的高通量方法。

An antiviral drug screening system for enterovirus 71 based on an improved plaque assay: A potential high-throughput method.

机构信息

Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, Guangdong Institute of Gastroenterology, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China.

Department of Clinical Laboratory, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China.

出版信息

J Med Virol. 2019 Aug;91(8):1440-1447. doi: 10.1002/jmv.25463. Epub 2019 Apr 1.

DOI:10.1002/jmv.25463
PMID:30900754
Abstract

Plaque assay plays an irreplaceable role in a variety of virological studies, including determining titers of viruses. Our previous study showed that a simple and highly repeatable plaque assay could be used for enterovirus 71 (EV-A71). Now, we show that using a subclone of a clinical EV-A71 isolate and a rhabdomyosarcoma cell line (RD), a plaque assay based on an EV-A71/RD model could exhibit the most rapid formation of plaques (<2 days), with much higher repeatability and consistency. Inspired by a plaque inhibitory test for testing ribavirin and interferon, as well as a plaque reduction neutralization test, this modified method has been used to establish a convenient system by using 96-well plates for screening anti-EV-A71 drugs from a 130-compound library containing multiple types of inhibitors. Nine candidate effective compounds for EV-A71 have been screened out, and among them, nobiletin (flavonoid) was found to be a novel effective compound at the concentration of 10 μM. Our findings imply that this improved method based on an EV-A71/RD model proved to be a potential high-throughput method in screening novel antiviral drugs for EV-A71. Undoubtedly, this method can also be applied to other viruses that can produce an obvious cytopathic effect.

摘要

空斑试验在各种病毒学研究中发挥着不可替代的作用,包括测定病毒的滴度。我们之前的研究表明,一种简单且高度可重复的空斑试验可用于肠道病毒 71(EV-A71)。现在,我们证明了使用临床 EV-A71 分离株的亚克隆和横纹肌肉瘤细胞系(RD),基于 EV-A71/RD 模型的空斑试验可以最快形成空斑(<2 天),具有更高的可重复性和一致性。受用于测试利巴韦林和干扰素的空斑抑制试验以及空斑减少中和试验的启发,我们使用 96 孔板修改了该方法,建立了一个方便的系统,用于从包含多种抑制剂的 130 种化合物文库中筛选抗 EV-A71 药物。已经筛选出 9 种针对 EV-A71 的候选有效化合物,其中,在 10 μM 的浓度下,橙皮素(类黄酮)被发现是一种新型有效化合物。我们的研究结果表明,基于 EV-A71/RD 模型的这种改进方法已被证明是筛选 EV-A71 新型抗病毒药物的一种有潜力的高通量方法。毫无疑问,这种方法也可以应用于能够产生明显细胞病变效应的其他病毒。

相似文献

1
An antiviral drug screening system for enterovirus 71 based on an improved plaque assay: A potential high-throughput method.基于改良噬斑法的肠道病毒 71 型抗病毒药物筛选系统:一种有潜力的高通量方法。
J Med Virol. 2019 Aug;91(8):1440-1447. doi: 10.1002/jmv.25463. Epub 2019 Apr 1.
2
Fisetin and rutin as 3C protease inhibitors of enterovirus A71.金雀异黄素和芦丁作为肠道病毒 A71 的 3C 蛋白酶抑制剂。
J Virol Methods. 2012 Jun;182(1-2):93-8. doi: 10.1016/j.jviromet.2012.03.020. Epub 2012 Mar 23.
3
Antiviral Potential of a Novel Compound CW-33 against Enterovirus A71 via Inhibition of Viral 2A Protease.新型化合物CW-33通过抑制病毒2A蛋白酶对肠道病毒A71的抗病毒潜力
Viruses. 2015 Jun 17;7(6):3155-71. doi: 10.3390/v7062764.
4
Characterization of three small molecule inhibitors of enterovirus 71 identified from screening of a library of natural products.从天然产物文库筛选中鉴定出的三种肠道病毒71小分子抑制剂的特性
Antiviral Res. 2017 Jul;143:85-96. doi: 10.1016/j.antiviral.2017.04.006. Epub 2017 Apr 13.
5
Inhibition of Enterovirus A71 by a Novel 2-Phenyl-Benzimidazole Derivative.新型 2-苯基苯并咪唑衍生物抑制肠道病毒 A71。
Viruses. 2021 Jan 4;13(1):58. doi: 10.3390/v13010058.
6
Identification of fangchinoline as a broad-spectrum enterovirus inhibitor through reporter virus based high-content screening.通过基于报告病毒的高通量筛选鉴定蝙蝠葛苏林碱为广谱肠道病毒抑制剂。
Virol Sin. 2024 Apr;39(2):301-308. doi: 10.1016/j.virs.2024.02.006. Epub 2024 Mar 5.
7
Rosmarinic acid exhibits broad anti-enterovirus A71 activity by inhibiting the interaction between the five-fold axis of capsid VP1 and cognate sulfated receptors.迷迭香酸通过抑制衣壳 VP1 五倍轴与同源硫酸化受体之间的相互作用,表现出广泛的抗肠道病毒 A71 活性。
Emerg Microbes Infect. 2020 Dec;9(1):1194-1205. doi: 10.1080/22221751.2020.1767512.
8
Antiviral activity of silymarin in comparison with baicalein against EV-A71.水飞蓟素与黄芩素抗 EV-A71 的抗病毒活性比较。
BMC Complement Med Ther. 2020 Mar 23;20(1):97. doi: 10.1186/s12906-020-2880-2.
9
In vitro and in vivo studies of a potent capsid-binding inhibitor of enterovirus 71.肠道病毒71型一种强效衣壳结合抑制剂的体外和体内研究
J Antimicrob Chemother. 2016 Jul;71(7):1922-32. doi: 10.1093/jac/dkw101. Epub 2016 Apr 19.
10
Susceptibilities of enterovirus D68, enterovirus 71, and rhinovirus 87 strains to various antiviral compounds.肠道病毒D68型、肠道病毒71型和鼻病毒87型毒株对多种抗病毒化合物的敏感性。
Antiviral Res. 2016 Jul;131:61-5. doi: 10.1016/j.antiviral.2016.04.003. Epub 2016 Apr 7.

引用本文的文献

1
Screening and verification of antiviral compounds against HSV-1 using a method based on a plaque inhibition assay.基于噬斑抑制试验的抗单纯疱疹病毒 1 型化合物的筛选与验证方法。
BMC Infect Dis. 2023 Dec 19;23(1):890. doi: 10.1186/s12879-023-08843-3.
2
Molecular docking study of various 3C protease proteins and their potential inhibitors.多种3C蛋白酶蛋白及其潜在抑制剂的分子对接研究。
Front Microbiol. 2022 Sep 29;13:987801. doi: 10.3389/fmicb.2022.987801. eCollection 2022.
3
Machine-learning-based automated quantification machine for virus plaque assay counting.
基于机器学习的病毒蚀斑试验计数自动定量机器。
PeerJ Comput Sci. 2022 Mar 4;8:e878. doi: 10.7717/peerj-cs.878. eCollection 2022.
4
Nanotechnology Applications of Flavonoids for Viral Diseases.黄酮类化合物在病毒疾病中的纳米技术应用
Pharmaceutics. 2021 Nov 8;13(11):1895. doi: 10.3390/pharmaceutics13111895.
5
From Ocean to Medicine: Pharmaceutical Applications of Metabolites from Marine Bacteria.从海洋到医学:海洋细菌代谢产物的药物应用
Antibiotics (Basel). 2020 Jul 28;9(8):455. doi: 10.3390/antibiotics9080455.
6
Flavonoids as Antiviral Agents for ().黄酮类化合物作为抗病毒药物用于()。
Viruses. 2020 Feb 6;12(2):184. doi: 10.3390/v12020184.